版本:
中国

BRIEF-Glaukos Corp says international study shows two Glaukos istent trabecular micro-bypass stents and one topical medication deliver sustained IOP reduction

April 13 Glaukos Corp

* Glaukos Corp says international study shows two glaukos istent trabecular micro-bypass stents and one topical medication deliver sustained IOP reduction

* Safety profile was favorable with no intraoperative or device-related adverse events reported Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐